Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

Back to Contracts

Developing a novel strategy to preserve fertility and; long-term health after cancer treatment

Awarded

GA587953Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The National Health and Medical Research Council of the Australian Government is overseeing a five year project titled Developing a novel strategy to preserve fertility and long-term health after cancer treatment. This initiative, identified by solicitation number GA587953, focuses on testing a new drug designed to protect fertility and prevent early menopause in female cancer survivors, aiming to improve the overall quality of life and long-term health outcomes for young patients. The research will be performed in Clayton, Australia. For further information or inquiries, the NHMRC Research Help Centre serves as the primary point of contact for this federal agency project.

General Info

NHMRC five-year project testing a drug to preserve female fertility after cancer treatment.

Agency

Australian Government → National Health and Medical Research Council (NHMRC)

Contract Value

$690,747.48

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)

Place of Performance

Clayton, VIC, 3800, AUS

Set-Aside

NONE

Awardee

Monash University

Award Issued Date

10/26/2026, 12:00:00 AM UTC

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded

PostedOct 26

Contract opportunity posted

AwardedOct 26

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyAustralian Government → National Health and Medical Research Council (NHMRC)

Contacts1 person available

OfficeN/A

Organization / AgencyAustralian Government → National Health and Medical Research Council (NHMRC)

Office AddressN/A

Contacts

NHMRC Research Help Centre

contact@example.gov

Full Description

Show more

Lifesaving cancer treatments often cause serious side effects, with many women facing infertility and early menopause as a result. These issues can greatly impact the quality of life of female cancer survivors. As more young people survive cancer, there is a growing need to prioritise their long-term health and wellbeing. Over the next 5 years, I will thoroughly test a promising new drug that could protect fertility and health during cancer treatment, supporting better outcomes for survivors.

Similar Contracts

Same NAICS industry code

Precision Prevention & Biological Pathway ResearchThe Precision Prevention and Biological Pathway Research subcontract supports prime contractors on Defense Health Agency Alzheimer’s Research Program projects. The primary objective is to conduct research linking service-related exposures to AD/ADRD biological pathways by quantifying military-relevant risk factors. This technical work involves the use of proteomics tools and genomic sequencing to map these biological pathways, culminating in the delivery of detailed research reports and data. Performance of this contract takes place in Frederick, Maryland, under NAICS code 541714. Due to the nature of the study, the contractor must obtain IRB approval and maintain all necessary Human Subjects Research certifications. Interested parties should note the response deadline of December 4, 2026.

Defense Health Agency

POSTED

about 11 hours ago

DEADLINE

in about 1 month

Blood-Based Biomarker Validation & ScalingThis subcontract focuses on the validation and scaling of blood-based biomarkers to support prime contractors within the Defense Health Agency Alzheimer’s Research Program. The scope of work involves performing detailed laboratory analysis of blood samples, validating the sensitivity and specificity of assays, and establishing scalable testing protocols. These operations must utilize Simoa equipment and biobanking systems while adhering strictly to GLP standards and maintaining CLIA certification. The project is managed under the Department of Defense and is centered in Frederick, Maryland. The primary objective is the delivery of validated, scalable biomarker assays and protocols to advance research goals. Interested parties should note the response deadline of December 4, 2026, and the classification of the work under NAICS code 541714.

Defense Health Agency

POSTED

about 11 hours ago

DEADLINE

in about 1 month

RFI Alzheimer’s Research Program (AZRP) Public

Solicitation # HT9427RFI2027AZRP

The Defense Health Agency, through the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027AZRP to gather strategic feedback for the fiscal year 2027 Alzheimer’s Research Program. The primary objective is to identify research focus areas and funding opportunities aimed at mitigating the impact of Alzheimer's and related dementias, specifically those associated with traumatic brain injury, military service, and diverse risks. The program seeks to improve the quality of life for Service Members, Veterans, and their families by funding solution-oriented research, including the development of digital and blood-based biomarkers for early diagnosis and the creation of precision prevention strategies. This action is strictly for information and planning purposes and does not constitute a formal solicitation, request for proposals, or request for quotations. No contracts will be awarded based on this announcement, and FY27 funds have not yet been appropriated. Interested parties from academia, industry, non-profit organizations, and federal agencies are invited to provide feedback via Survey Monkey by December 4, 2026. Respondents are cautioned not to submit proprietary or sensitive information through the survey portal as it cannot be protected. The effort is categorized under NAICS code 541714 and is managed by the Department of Defense in Fort Detrick, Maryland.

Defense Health Agency

POSTED

about 11 hours ago

DEADLINE

in about 1 month

Traumatic Brain Injury and Psychological Health Research Program Public Request for Information

Solicitation # HT9427RFI2027TBIPHRP

The Defense Health Agency, under the Department of Defense and the Congressionally Directed Medical Research Programs, has issued a Request for Information under solicitation number HT9427RFI2027TBIPHRP. This action is strictly for strategic planning and is not a formal solicitation, request for proposals, or request for quotations. The primary objective is to gather feedback from academia, industry, non-profit organizations, and the public to inform the research focus areas and funding opportunities for the fiscal year 2027 Traumatic Brain Injury and Psychological Health Research Program. The program aims to optimize the prevention, assessment, and treatment of psychological health conditions and traumatic brain injuries to benefit Service Members, Veterans, and the general public. Interested parties are asked to provide input on research gaps and funding priorities, specifically regarding the prevention, screening, diagnosis, and treatment of these conditions. Responses must be submitted via Survey Monkey by December 11, 2026. Because the government cannot protect proprietary or sensitive information submitted through the survey platform, such data should not be included. This inquiry does not commit the program to incorporating the feedback into future funding opportunities, and no contract will be awarded based on this specific announcement. All inquiries regarding this RFI should be directed to Patrick M. Younkins.

Defense Health Agency

POSTED

about 11 hours ago

DEADLINE

in about 1 month

Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_NPIVS_27

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. The objective is to maintain a permanent readiness posture against high-threat influenza and other viruses with pandemic potential. Selected contractors will provide vaccines, antigens, and adjuvants, and generate necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data for FDA submission to support rapid regulatory decisions. To be eligible, offerors must produce vaccines against influenza strains with pandemic potential and demonstrate successful manufacturing experience by holding a U.S. influenza vaccine license or having submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The government intends to award contracts to four offerors based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology. Evaluation factors include capabilities, past performance, and price, with capabilities being the most significant. The contract structure consists of a 60-month base period and a 60-month option period, with a minimum guarantee of 50,000 dollars. Key requirements include the development of comprehensive manufacturing, business continuity, and supply continuity plans, as well as adherence to strict ASPR security and FDA CGMP standards. Performance will be managed through individual task orders and BPA call orders, with invoicing conducted quarterly via the Department of Treasury Invoice Processing Platform.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

USDA SBIR/STTR Topic 8.2 — Plant Production and Protection - Biology

Solicitation # USDA-NIFA-TOPIC-8.2

The USDA National Institute of Food and Agriculture is soliciting proposals under Topic 8.2 for Plant Production and Protection - Biology. This initiative focuses on advancing crop production and protection through the development of innovative plant breeding methods, diagnostic technologies for diseases, and the creation of new food and non-food crop plants. Research efforts are directed toward improving plant characteristics to mitigate biotic and abiotic stresses, developing new genotypes for commercial applications, and creating tools to support the health of natural and domesticated pollinators. This opportunity is a total small business set-aside under the SBIR/STTR mandate, restricting eligibility to companies with fewer than 500 employees. Managed by the United States Department of Agriculture, the program is led by Dr. Christopher Philips. Interested parties can find further details and application guidelines through the NIFA website.

National Institute of Food and Agriculture

POSTED

DEADLINE

Quantitative Analysis of Longitudinal MR Images

Solicitation # 75N98027R00005

Solicitation 75N98027R00005 is a Sources Sought notice issued by the National Institute on Aging (NIA) to identify qualified companies capable of performing quantitative analysis of longitudinal Magnetic Resonance (MR) images. The project supports the Baltimore Longitudinal Study of Aging (BLSA) by processing 300 newly acquired MR datasets to characterize brain aging trajectories and identify predictors of cognitive decline and Alzheimer’s disease. The selected contractor will provide specialized, non-commercial services to deliver global and regional tissue volumes, lesion quantification, and machine learning-derived scores, such as SPARE-AD, while ensuring longitudinal consistency with data acquired since 1994. The anticipated contract will be a firm fixed price award with a period of performance of one year. Key deliverables include quantitative volumetric results, intermediate processing files, and registration maps for PET overlay, submitted every six months, concluding with a final report. Technical requirements emphasize the use of established image analysis tools and adherence to FISMA/FedRAMP-aligned data security controls to protect participant confidentiality. Interested respondents must submit a capability statement by November 9, 2026, to Contract Specialist Sneha Singh. The submission must be limited to ten pages and include the company's Unique Entity ID, NAICS code 541714, professional qualifications of personnel, and any applicable GSA schedules or government-wide acquisition contracts. Small businesses are encouraged to respond to this market research effort to help the government determine the appropriate acquisition method.

National Institutes Of Health Olao

POSTED

DEADLINE

Q--AMPLICON SEQUENCING SERVICES

Solicitation # 140G0226Q0047

The Department of the Interior, through the USGS OAG Denver Acquisition Branch, is soliciting quotations for a Blanket Purchase Agreement (BPA) to provide next-generation amplicon sequencing services for the Michigan Bacteriological Research Laboratory. The agreement has a not-to-exceed value of $250,000 over a five-year period of performance from September 17, 2026, to September 16, 2031. The scope of work includes non-personal services such as library preparation for 16S V4 amplicon sequencing, library pooling, and sequencing using Illumina MiSeq or AVITI platforms to support research on bacterial pathogens, antibiotic resistance, and microbial ecology. Key deliverables include demultiplexed raw data and reporting metrics, with a required delivery turnaround of 60 business days from sample receipt. Award decisions will be based on technical and priced factors, with non-priced factors carrying significantly more weight. Technical evaluations will focus on the contractor's on-site equipment, personnel experience, quality control procedures, business establishment, and a capabilities narrative. Offerors must also provide two customer references from the last five years. The contract is subject to various federal regulations, including specific security prohibitions regarding certain telecommunications equipment and the requirement for electronic invoicing through the Invoice Processing Platform System. Quotations are due by November 5, 2026, and must be submitted via email to the primary point of contact.

Ofc Of Acquisition Grants-Denver

POSTED

DEADLINE

ARPA-H Emerging Health Innovators (EHI) Initiative

Solicitation # ARPA-H-SOL-26-150

The Advanced Research Projects Agency for Health (ARPA-H) Emerging Health Innovators (EHI) initiative, solicitation ARPA-H-SOL-26-150, seeks to identify and engage early-career investigators to develop cutting-edge biomedical, health, and community-engaged research. This opportunity is open to researchers from academic, nonprofit, and industry organizations, provided the Principal Investigator is within eight years of completing their first terminal degree. The initiative covers 16 specific topic areas, including AI in life sciences, brain stimulation, and human tissue platforms. Awards are issued as Other Transaction (OT) agreements, which are not subject to the Federal Acquisition Regulation (FAR). The selection process is a two-step submission involving an initial anonymized Solution Summary and a subsequent Full Proposal for selected candidates. Successful awards have a total value not to exceed 1,050,000 dollars over a three-year period, consisting of a 24-month base period capped at 700,000 dollars and an optional 12-month Director's Award period capped at 350,000 dollars. Payments are structured as fixed payments triggered by the completion of 12 discrete, measurable milestones. Full proposals are evaluated based on technical merit, innovativeness, feasibility, alignment with the ARPA-H mission to accelerate health outcomes, and price reasonableness. Administrative requirements include mandatory registration in SAM.gov and the use of the ARPA-H Solutions site for all submissions. Proposers must adhere to strict formatting templates for technical and management proposals, milestone schedules, and national policy requirements, including disclosures regarding organizational conflicts of interest and research security. Performance is monitored through a formal inspection and acceptance process where the government reviews deliverables within 14 calendar days. The tentative award start date is June 30, 2027, with full proposals due by February 10, 2027.

Advanced Research Projects Agency For Health (arpa-H)

POSTED

DEADLINE

In Vivo Biodistribution Studies and Bioluminescence ImagingThis subcontract, titled In Vivo Biodistribution Studies and Bioluminescence Imaging, supports biotechnology projects for the Department of Veterans Affairs at the Harry S Truman Memorial Veterans Hospital. The selected provider will conduct animal studies to evaluate AAV vector specificity and off-target transduction. Key technical responsibilities include administering vectors to animal models, utilizing bioluminescence imaging via IVIS to track localization, and performing tissue harvesting for qPCR analysis to generate comprehensive biodistribution data reports. The work will be performed in Columbia, Missouri, and requires strict adherence to AAALAC and FELASA health standards. This opportunity is categorized under NAICS code 541714 and is managed by Rpo East. Interested parties should note the response deadline of November 4, 2026.

Rpo East (36C24E)

POSTED

DEADLINE

AAV Vector Binding and Internalization Testing (Kidney Tissue)This subcontract, issued by the Department of Veterans Affairs Rpo East for biotechnology projects at the Harry S Truman Memorial Veterans Hospital, involves specialized laboratory testing to verify the binding and internalization of AAV vectors. The selected provider will be responsible for preparing kidney tissue slices, incubating them with modified AAV vectors, and utilizing qPCR platforms, Agilent Fragment Analyzers, and fluorescence microscopy to analyze efficiency. All work must be performed in BSL-2 facilities, and the contractor is required to hold BSL-2 certification. The primary deliverable for this engagement is the provision of detailed validation reports focusing on internalization rates and binding affinity. The project is categorized under NAICS code 541714 and is based in Columbia, Missouri. Interested parties must respond by November 4, 2026.

Rpo East (36C24E)

POSTED

DEADLINE

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Solicitation # W911SR-26-R-HEAL

The Capability Program Executive for Chemical, Biological, Radiological, and Nuclear Defense (CPE CBRND) is establishing the Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) ecosystem. This continuous, open announcement seeks to build a network of pre-qualified partners to accelerate the development, testing, and fielding of next-generation medical defense solutions. The program focuses on two primary pillars: host-targeted resilience, which targets critical host systems like neurological and respiratory pathways to enhance physiological protection, and threat-targeted neutralization, which focuses on broad-spectrum countermeasures for prophylaxis and acute treatment. Priority is given to candidates designed for austere environments, featuring environmental stability without cold-chain reliance and simplified administration routes such as oral or intranasal delivery. The government is inviting two types of participants: MCM Development Collaborators, ranging from Phase I products through FDA licensure, and MCM Development Support Collaborators, such as CROs and CDMOs specializing in preclinical testing, cGMP manufacturing, and regulatory submissions. Interested parties must submit a white paper of no more than five pages detailing their product descriptions, efficacy data, regulatory status, and manufacturing capabilities. Acceptance into the PBA enables the subsequent award of project orders under the authority of 10 U.S.C sections 4021, 4022, and 4023. These agreements are not subject to the Competition in Contracting Act of 1984. All prospective awardees must be registered in the System for Award Management (SAM) database to receive payment.

POSTED

DEADLINE

More opportunities from Australian Government → National Health and Medical Research Council (NHMRC)

Same awarding agency

MRFF – EPCDRI – 2026 Improving Health Interventions and Services through Implementation Research Grant Opportunity

Solicitation # GO8671

The MRFF EPCDRI 2026 Improving Health Interventions and Services through Implementation Research Grant Opportunity, administered by the NHMRC on behalf of the Australian Government, provides financial assistance for medical research and innovation. The program is divided into two distinct streams: Stream 1 focuses on co-designed proof of concept or pilot studies to establish feasibility and impact, while Stream 2 supports multidisciplinary implementation research aimed at improving the adoption and scaling of evidence-based health interventions. Applicants must partner with health service providers and consumers, focus on priority populations, and demonstrate how their novel research will translate into tangible health benefits for Australians. This federal opportunity offers a total program funding pool of 20 million dollars, with an award ceiling of 5 million dollars. Interested eligible organizations must submit their applications to only one of the two available streams by the deadline of March 3, 2027. The primary goal of the initiative is to enhance the quality and effectiveness of health and wellbeing services across Australia by building a robust evidence base for the implementation of health interventions.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

MRFF – Rapid Applied Research Translation Initiative – Rapid Applied Research Translation Grant Opportunity

Solicitation # GO8672

The Rapid Applied Research Translation Grant Opportunity, administered by the National Health and Medical Research Council on behalf of the Australian Government Department of Health, Disability and Ageing, provides financial assistance for medical research and innovation. The program focuses on late-stage translational research designed to bridge gaps in best practice health care and accelerate the integration of research findings into clinical care and health policy. Projects must involve all relevant stakeholders, including providers and consumers, to ensure outcomes are directly applicable to health services. Funding is available through two distinct streams, with Stream 1 open to organizations in any location and Stream 2 specifically reserved for those in regional, rural, or remote areas as defined by the Modified Monash Model. Individual awards range from 250,000 to 5,000,000 dollars, with total program funding amounting to 48,100,000 dollars. Applications must be submitted by March 10, 2027, and applicants may only apply to one of the two available funding streams.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Cancer Australia Research Initiative Targeted Call for Research: Liver Cancer Prevention and Early Detection 2026

Solicitation # GO8673

The Cancer Australia Research Initiative Targeted Call for Research: Liver Cancer Prevention and Early Detection 2026 is a federal grant opportunity jointly funded by Cancer Australia and the National Health and Medical Research Council. With a total program funding of 7 million dollars and an award ceiling of 1 million dollars, this initiative seeks to reduce the incidence and impact of liver cancer in Australia. The program emphasizes translational potential and the development of the cancer research workforce, specifically providing opportunities for early to mid-career researchers. Eligible proposals must focus on improving the early identification of high-risk individuals and translating that knowledge into equitable, evidence-based care pathways. Key research priorities include risk stratification and prediction tools, the creation of effective referral and surveillance systems, and the identification of health system barriers. Additionally, the initiative prioritizes the development of culturally safe and community-led approaches to reach priority population groups and reduce stigma. Interested parties must submit their responses by December 16, 2026.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

in about 2 months

2027 NHMRC-European Partnership on One Health Antimicrobial ResistanceThe 2027 NHMRC-European Partnership on One Health Antimicrobial Resistance is a forecast initiative by the National Health and Medical Research Council of the Commonwealth of Australia. This scheme is designed to support Australian researchers in collaborating on transnational projects aimed at addressing antimicrobial resistance challenges across various sectors and One Health domains. Eligibility is limited to Australia-based researchers who have received an invitation from the European Partnership on One Health Antimicrobial Resistance to submit a full proposal. The program focuses on three primary research topics: modeling AMR transmission dynamics to assist public authority decision-making, characterizing the role of host commensal micro-organisms to develop selective decolonizing solutions, and improving tools to reduce resistant bacteria and fungi in environmental hotspots. Interested parties can seek further information through the NHMRC Research Help Centre or the official European Partnership on One Health Antimicrobial Resistance website.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

MRFF – EPCDRI – 2026 Improving the Health of People with Disability Grant Opportunity

Solicitation # GO8647

The MRFF EPCDRI 2026 Improving the Health of People with Disability Grant Opportunity, solicitation number GO8647, provides financial assistance for medical research and innovation aimed at enhancing health outcomes for people with disability. Administered by the National Health and Medical Research Council on behalf of the Australian Government Department of Health, Disability and Ageing, the program offers total funding of 30 million dollars with an award ceiling of 5 million dollars. All projects must utilize a co-design approach involving the health and disability sector and individuals with lived experience. The grant is divided into four targeted research streams focusing on person-centered health care transitions across life stages, the development of preventive health interventions, the improvement of health self-efficacy and literacy, and interventions addressing intersectional disadvantage. Interested eligible organizations must submit their responses by the deadline of March 3, 2027. Performance of the awarded projects is expected to take place within Australia.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

MRFF – Clinical Trials Activity Initiative – 2026 Clinical Trials Activity Grant Opportunity

Solicitation # GO8645

The Medical Research Future Fund Clinical Trials Activity Initiative is a federal grant opportunity administered by the National Health and Medical Research Council on behalf of the Australian Government. The program aims to enhance the evidence base for clinical care and increase patient access to high-quality trials within Australia. Funding is available across four distinct streams: an incubator for pilot studies on rare diseases or unmet needs, targeted research for clinical trials on rare conditions, trials addressing health technology assessment evidence gaps, and prevention trials focused on early intervention strategies. This initiative offers a total program funding pool of 136 million dollars, with an award ceiling of 5 million dollars per project. Interested eligible organizations must submit their proposals by the deadline of April 7, 2027. The ultimate goal of the initiative is to improve the overall health and wellbeing of Australians by investing in medical innovation and evidence-based healthcare delivery.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Synergy Grants 2027 forecast opportunity

POSTED

about 1 month ago

DEADLINE

NHMRC Centres of Research Excellence 2027

Solicitation # GO8615

The NHMRC Centres of Research Excellence 2027 grant opportunity, managed by the Australian Government, aims to improve health outcomes by translating research into policy and practice. The scheme focuses on supporting innovative, collaborative research across basic science, clinical, health services, and public health sectors while building capacity and capability within the health and medical research workforce. Eligible applicants can apply through specific streams and may organize their Centre as a single entity or a geographically disparate network, with strong encouragement to engage in national and international collaborations. This federal funding opportunity, identified by solicitation number GO8615, offers a total program funding pool of 60 million dollars, with individual awards set at 3 million dollars. Interested parties must submit their responses by the deadline of November 4, 2026. The program is designed to foster high-quality research environments that bridge the gap between scientific discovery and practical health application within Australia.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 1 month ago

DEADLINE

2026 Clinical Trials and Cohort Studies

Solicitation # GO8599

The 2026 Clinical Trials and Cohort Studies grant, administered by the National Health and Medical Research Council of the Australian Government, provides up to 75 million dollars in total program funding. The scheme supports high-quality clinical trials and cohort studies of any size, including retrospective studies, that aim to fill knowledge gaps and improve human health, healthcare practice, or policy. Funding is specifically targeted toward providing reliable evidence on health-related interventions and the impact of risk factors on health outcomes. Applicants must submit their proposals by November 4, 2026. It is important to note that this grant is not intended for ongoing support or infrastructure costs. Successful grantees are required to report their progress against established milestones every twelve months to ensure the research leads to implementable findings for the benefit of public wellbeing.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

about 2 months ago

DEADLINE

Targeted Call for Research: Strengthening the Aboriginal and Torres Strait Islander Health Workforce Pipeline 2026

Solicitation # GO8600

The Targeted Call for Research: Strengthening the Aboriginal and Torres Strait Islander Health Workforce Pipeline 2026 is a federal grant opportunity issued by the National Health and Medical Research Council under the Australian Government. With total program funding of 5,000,000 dollars, this initiative seeks to stimulate research that enhances health equity for Aboriginal and Torres Strait Islander peoples by building a more sustainable, culturally safe, and robust health workforce. The solicitation, identified as GO8600, was posted on September 9, 2026, with a response deadline of November 4, 2026. The primary objectives of this call are to identify the barriers and enablers affecting the entire workforce pipeline, from recruitment and education to leadership and career progression. The program aims to evaluate the effectiveness of current workforce strategies, strengthen research capabilities through meaningful participation and training, and develop practical, culturally responsive tools for planning and evaluation. Ultimately, the research is intended to produce evidence-based, gender-balanced recommendations that lead to scalable improvements in the healthcare system and better health outcomes for indigenous communities.

Research and Development in the Social Sciences and Humanities

POSTED

about 2 months ago

DEADLINE

MRFF – CRI - 2026 Clinician Researchers: Nurses, Midwives and Allied Health Grant Opportunity

Solicitation # GO8568

The MRFF 2026 Clinician Researchers grant opportunity provides financial assistance for medical research and innovation led by nurses, midwives, and allied health professionals. Administered by the NHMRC on behalf of the Australian Government, the program aims to improve the health and well-being of Australians by enhancing healthcare quality and system performance. Applicants must choose between two distinct streams: Stream 1 focuses on accelerating the translation of evidence into practice within health services, while Stream 2 targets workforce innovation, service improvement, and health system performance. The program offers a total funding pool of 40 million dollars, with an award ceiling of 1.5 million dollars. Interested parties must be listed as eligible organizations and submit their applications by the deadline of November 11, 2026. Each application is restricted to a single research stream to ensure targeted outcomes in patient care, local health priorities, and the research capacity of clinicians.

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Targeted Call for Research: Strengthening the Aboriginal and Torres Strait Islander Health Workforce Pipeline 2026The National Health and Medical Research Council of the Commonwealth of Australia is forecasting a Targeted Call for Research titled Strengthening the Aboriginal and Torres Strait Islander Health Workforce Pipeline 2026. This one-time grant opportunity is designed to stimulate research and evaluation aimed at improving the health workforce pipeline for Aboriginal and Torres Strait Islander people. The initiative focuses on the entire professional trajectory, including attraction, entry, education on workforce pathways, retention, career progression, and leadership. The primary goal of this research is to generate evidence that supports effective workforce planning and development to ultimately improve health equity outcomes for Australians. Interested parties can find further information through the NHMRC Research Help Centre or via the official grants portal. The forecast was posted on August 11, 2026.

Research and Development in the Social Sciences and Humanities

POSTED

DEADLINE

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Join 750+ contractors already using CLEATUS